Millennium Management’s TRACON Pharmaceuticals TCON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-3,733
Closed -$32.1K – 6708
2024
Q1
$32.1K Sell
3,733
-5,840
-61% -$27.9K ﹤0.01% 5759
2023
Q4
$33.5K Buy
+9,573
New +$33.7K ﹤0.01% 5546
2023
Q3
– Sell
-1,058
Closed -$6.16K – 6704
2023
Q2
$6.16K Buy
1,058
+470
+80% +$8.59K ﹤0.01% 5833
2023
Q1
$22K Buy
+588
New +$19.3K ﹤0.01% 5845
2022
Q4
– Sell
-1,720
Closed -$57K – 7213
2022
Q3
$57K Sell
1,720
-2,041
-54% -$77.9K ﹤0.01% 6142
2022
Q2
$150K Buy
+3,761
New +$146K ﹤0.01% 5770
2021
Q4
– Sell
-6,974
Closed -$540K – 7526
2021
Q3
$540K Buy
+6,974
New +$590K ﹤0.01% 5277
2021
Q2
– Sell
-2,590
Closed -$426K – 7265
2021
Q1
$426K Sell
2,590
-4,865
-65% -$937K ﹤0.01% 4953
2020
Q4
$1.74M Buy
7,455
+3,997
+116% +$556K ﹤0.01% 3343
2020
Q3
$358K Sell
3,458
-131
-4% -$7.02K ﹤0.01% 3748
2020
Q2
$141K Buy
3,589
+2,143
+148% +$84.8K ﹤0.01% 3928
2020
Q1
$48K Buy
+1,446
New +$84K ﹤0.01% 3671
2018
Q4
– Sell
-372
Closed -$152K – 4279
2018
Q3
$152K Sell
372
-120
-24% -$55.6K ﹤0.01% 3686
2018
Q2
$266K Buy
492
+309
+169% +$164K ﹤0.01% 3446
2018
Q1
$84K Buy
183
+52
+40% +$28.4K ﹤0.01% 3493
2017
Q4
$88K Buy
131
+72
+122% +$43.5K ﹤0.01% 3678
2017
Q3
$37K Buy
+59
New +$30.7K ﹤0.01% 3426
2015
Q2
– Sell
-132
Closed -$372K – 3956
2015
Q1
$372K Buy
+132
New +$347K ﹤0.01% 2916

Other funds holding TCON

Millennium Management's TCON Position: Q2 2024 in Review

Millennium Management sold out of TRACON Pharmaceuticals (TCON) in Q2 2024, closing a stake of 3,733 shares — an estimated $32.1K sold.

Millennium Management first reported a position in TCON in Q1 2015 and held it in 18 quarters. The position peaked at $1.74M in Q4 2020. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

  • Millennium Management reported no remaining TRACON Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 3,733 TRACON Pharmaceuticals shares in Q2 2024, an estimated $32.1K.
  • Millennium Management first reported a position in TRACON Pharmaceuticals in Q1 2015 and held it in 18 quarters.
  • Millennium Management's TRACON Pharmaceuticals position peaked at $1.74M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.